ChemoCentryx (CCXI) Tops Q2 EPS by 1c
Tweet
Share
E-mailGet Alerts CCXI Hot Sheet
Join SI Premium – FREE
ChemoCentryx (NASDAQ: CCXI) reported Q2 EPS of ($0.28), $0.01 better than the analyst estimate of ($0.29).
For earnings history and earnings-related data on ChemoCentryx (CCXI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies upgrades Five Below to Buy, sees path to TJX-like re-rating
- Range Impact, Inc. (RNGE) Reports Q2 Loss of $0.02
- SPAR Group (SGRP) Reports Q2 EPS of $0.04
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
